CEACAM5 and colorectal carcinoma: Denmark participated in the international multicenter randomized clinical trial COLOFOL,46 which did not show improved 5-year overall survival or CRC-specific survival associated with more frequent CT scans and carcinoembryonic antigen measurements (5 times vs 2 times), which is why Denmark follows a surveillance program with 2 CT scans.